These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19876039)

  • 1. Asenapine.
    Meltzer HY; Dritselis A; Yasothan U; Kirkpatrick P
    Nat Rev Drug Discov; 2009 Nov; 8(11):843-4. PubMed ID: 19876039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania.
    Tarazi FI; Shahid M
    Drugs Today (Barc); 2009 Dec; 45(12):865-76. PubMed ID: 20135021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACS chemical neuroscience molecule spotlight on Saphris.
    Hopkins CR
    ACS Chem Neurosci; 2010 Apr; 1(4):263-4. PubMed ID: 22778826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asenapine: a clinical review of a second-generation antipsychotic.
    Stoner SC; Pace HA
    Clin Ther; 2012 May; 34(5):1023-40. PubMed ID: 22494521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iloperidone, asenapine and lurasidone: a primer on their current status.
    Tarazi FI; Stahl SM
    Expert Opin Pharmacother; 2012 Sep; 13(13):1911-22. PubMed ID: 22849428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asenapine approved for treatment of schizophrenia, bipolar disorder.
    Traynor K
    Am J Health Syst Pharm; 2009 Sep; 66(18):1596. PubMed ID: 19729558
    [No Abstract]   [Full Text] [Related]  

  • 8. Asenapine (Saphris) sublingual tablets for schizophrenia and bipolar disorder.
    Med Lett Drugs Ther; 2010 Feb; 52(1331):9-10. PubMed ID: 20216523
    [No Abstract]   [Full Text] [Related]  

  • 9. Asenapine: Pharmacological Aspects and Role in Psychiatric Disorders.
    Reyad AA; Mishriky R
    Psychiatr Danub; 2019 Jun; 31(2):157-161. PubMed ID: 31291219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asenapine: a review of acute and extension phase data in bipolar disorder.
    McIntyre RS
    CNS Neurosci Ther; 2011 Dec; 17(6):645-8. PubMed ID: 20950326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drug information. Saphris.
    Physician Assistants Prescribing Reference
    JAAPA; 2010 Mar; 23(3):16. PubMed ID: 20232719
    [No Abstract]   [Full Text] [Related]  

  • 12. Asenapine.
    Weber J; McCormack PL
    CNS Drugs; 2009 Sep; 23(9):781-92. PubMed ID: 19689168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics: the two new arrivals.
    Roman MW
    Issues Ment Health Nurs; 2011; 32(1):85-6. PubMed ID: 21208056
    [No Abstract]   [Full Text] [Related]  

  • 14. A Review of Asenapine in the Treatment of Bipolar Disorder.
    Vieta E; Montes JM
    Clin Drug Investig; 2018 Feb; 38(2):87-99. PubMed ID: 29067671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asenapine review, part II: clinical efficacy, safety and tolerability.
    Citrome L
    Expert Opin Drug Saf; 2014 Jun; 13(6):803-30. PubMed ID: 24793161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asenapine: a new antipsychotic option.
    Henry JM; Fuller MA
    J Pharm Pract; 2011 Oct; 24(5):447-51. PubMed ID: 22156709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical pinpoint pupils with asenapine.
    Gill JS; Jambunathan S; Wong S; Wong A
    Asia Pac Psychiatry; 2015 Jun; 7(2):230. PubMed ID: 25923587
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: meta-analyses of randomized-controlled trials.
    Vita A; De Peri L; Siracusano A; Sacchetti E;
    Int Clin Psychopharmacol; 2013 Sep; 28(5):219-27. PubMed ID: 23719049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial.
    Findling RL; Landbloom RL; Mackle M; Wu X; Snow-Adami L; Chang K; Durgam S
    Paediatr Drugs; 2016 Oct; 18(5):367-78. PubMed ID: 27461426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs: asenapine, iloperidone, and bepotastine besilate.
    Hussar DA; Abbas CA
    J Am Pharm Assoc (2003); 2010; 50(1):107-10. PubMed ID: 20097650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.